HCW Biologics Inc. Quarterly Current Ratio in % from Q1 2022 to Q3 2024

Taxonomy & unit: ratio: %
Description: The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary: HCW Biologics Inc. quarterly Current Ratio history and growth rate from Q1 2022 to Q3 2024.
HCW Biologics Inc. Current Ratio for the quarter ending September 30, 2024 was 22.7 %, a 96% decline year-over-year.

Current Ratio, Quarterly (%)

Current Ratio, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2024	22.7	-538	-96%	Sep 30, 2024
Q2 2024	56.8	-730	-92.8%	Jun 30, 2024
Q1 2024	144	-1.02K	-87.7%	Mar 31, 2024
Q4 2023	301	-1.43K	-82.6%	Dec 31, 2023
Q3 2023	560	-1.41K	-71.6%	Sep 30, 2023
Q2 2023	786	-1.36K	-63.4%	Jun 30, 2023
Q1 2023	1.17K	-115	-8.94%	Mar 31, 2023
Q4 2022	1.73K			Dec 31, 2022
Q3 2022	1.97K			Sep 30, 2022
Q2 2022	2.15K			Jun 30, 2022
Q1 2022	1.28K			Mar 31, 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.